Company Overview of Synedgen Inc.
Synedgen Inc., a biotechnology company, discovers and develops polysaccharide-based drugs using the science of glycomics. The company uses Glycomics Technology Platform that enables to design drugs with the ability to suppress inflammation, reduce infection, and improve healing. Its pipeline includes drugs for CF lung function, pulmonary infection, and COPD; and for gastrointestinal problems. Synedgen Inc. was founded in 2009 and is based in Claremont, California.
1420 North Claremont Boulevard
Suite 105 D
Claremont, CA 91711
Founded in 2009
Key Executives for Synedgen Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
August 30, 2017
October 28, 2016
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Synedgen Inc., please visit www.synedgen.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.